Endogenous MCP-1 promotes lung inflammation induced by LPS and LTA

Molecular Immunology

Volumn 48, Issue 12-13, 2011, Pages 1468-1476

  van Zoelen, Marieke A D ^a,b   Verstege, Marleen I ^a   Draing, Christian ^c   de Beer, Regina ^a   Veer, Cornelis van't ^a   Florquin, Sandrine ^a   Bresser, Paul ^a   van der Zee, Jaring S ^a   te Velde, Anje A ^a   von Aulock, Sonja ^c   van der Poll, Tom ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Animal models; Lipopolysaccharide; Lipoteichoic acid; Lung inflammation; Monocyte chemoattractant protein 1; Soluble receptor for advanced glycation end products

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; CLINICAL ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HISTOPATHOLOGY; HUMAN; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTROPHILS; PNEUMONIA; TEICHOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MUS; NEGIBACTERIA; POSIBACTERIA;

EID: 79957819966     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.04.001     Document Type: Article

References (45)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Amano H., Morimoto K., Senba M., Wang H., Ishida Y., Kumatori A., Yoshimine H., Oishi K., Mukaida N., Nagatake T. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J. Immunol. 2004, 172:398-409.
3. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., Hoebe K. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 2006, 24:353-389.
4. Beutler B., Rietschel E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 2003, 3:169-176.
5. Coelho A.L., Hogaboam C.M., Kunkel S.L. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev. 2005, 16:553-560.
6. Daly C., Rollins B.J. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 2003, 10:247-257.
7. Delayre-Orthez C., Becker J., Guenon I., Lagente V., Auwerx J., Frossard N., Pons F. PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir. Res. 2005, 6:91.
8. Dessing M.C., de Vos A.F., Florquin S., van der Poll T. Monocyte chemoattractant protein 1 does not contribute to protective immunity against pneumococcal pneumonia. Infect. Immun. 2006, 74:7021-7023.
9. Elizur A., Adair-Kirk T.L., Kelley D.G., Griffin G.L., Demello D.E., Senior R.M. Clara cells impact the pulmonary innate immune response to LPS. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293:L383-392.
10. Fillion I., Ouellet N., Simard M., Bergeron Y., Sato S., Bergeron M.G. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment. J. Immunol. 2001, 166:7353-7361.
11. Gao J.J., Xue Q., Zuvanich E.G., Haghi K.R., Morrison D.C. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect. Immun. 2001, 69:751-757.
12. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. Dis. 2002, 2:171-179.
13. Hoogerwerf J.J., de Vos A.F., Bresser P., van der Zee J.S., Pater J.M., de B.A., Tanck M., Lundell D.L., Her-Jenh C., Draing C., von Aulock S., van der Poll T. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am. J. Respir. Crit. Care Med. 2008, 178:34-41.
14. Knapp S., von Aulock S., Leendertse M., Haslinger I., Draing C., Golenbock D.T., van der Poll T. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J. Immunol. 2008, 180:3478-3484.
15. Knapp S., Wieland C.W., Florquin S., Pantophlet R., Dijkshoorn L., Tshimbalanga N., Akira S., van der Poll T. Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am. J. Respir. Crit. Care Med. 2006, 173:122-129.
16. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J. Immunol. 2001, 166:5161-5167.
17. Maris N.A., de Vos A.F., Dessing M.C., Spek C.A., Lutter R., Jansen H.M., van der Zee J.S., Bresser P., van der Poll T. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am. J. Respir. Crit. Care Med. 2005, 172:878-884.
18. Matsukawa A., Hogaboam C.M., Lukacs N.W., Lincoln P.M., Strieter R.M., Kunkel S.L. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J. Immunol. 1999, 163:6148-6154.
19. Matsukawa A., Hogaboam C.M., Lukacs N.W., Lincoln P.M., Strieter R.M., Kunkel S.L. Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. Exp. Mol. Pathol. 2000, 68:77-84.
20. Maus U., Herold S., Muth H., Maus R., Ermert L., Ermert M., Weissmann N., Rosseau S., Seeger W., Grimminger F., Lohmeyer J. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 280:L58-L68.
21. Maus U., von Grote K., Kuziel W.A., Mack M., Miller E.J., Cihak J., Stangassinger M., Maus R., Schlondorff D., Seeger W., Lohmeyer J. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am. J. Respir. Crit. Care Med. 2002, 166:268-273.
22. Morath S., Geyer A., Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 2001, 193:393-397.
23. Morath S., Geyer A., Spreitzer I., Hermann C., Hartung T. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 2002, 70:938-944.
24. Paine R., Rolfe M.W., Standiford T.J., Burdick M.D., Rollins B.J., Strieter R.M. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J. Immunol. 1993, 150:4561-4570.
25. Raghavendran K., Davidson B.A., Mullan B.A., Hutson A.D., Russo T.A., Manderscheid P.A., Woytash J.A., Holm B.A., Notter R.H., Knight P.R. Acid and particulate-induced aspiration lung injury in mice: importance of MCP-1. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289:L134-L143.
26. Rosseau S., Hammerl P., Maus U., Walmrath H.D., Schutte H., Grimminger F., Seeger W., Lohmeyer J. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279:L25-L35.
27. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000, 18:217-242.
28. Schmal H., Shanley T.P., Jones M.L., Friedl H.P., Ward P.A. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J. Immunol. 1996, 156:1963-1972.
29. Speyer C.L., Gao H., Rancilio N.J., Neff T.A., Huffnagle G.B., Sarma J.V., Ward P.A. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am. J. Pathol. 2004, 165:2187-2196.
30. Speyer C.L., Neff T.A., Warner R.L., Guo R.F., Sarma J.V., Riedemann N.C., Murphy M.E., Murphy H.S., Ward P.A. Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am. J. Pathol. 2003, 163:2319-2328.
31. Speyer C.L., Rancilio N.J., McClintock S.D., Crawford J.D., Gao H., Sarma J.V., Ward P.A. Regulatory effects of estrogen on acute lung inflammation in mice. Am. J. Physiol. Cell Physiol. 2005, 288:C881-C890.
32. Steinhauser M.L., Hogaboam C.M., Kunkel S.L., Lukacs N.W., Strieter R.M., Standiford T.J. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 1999, 162:392-399.
33. Strieter R.M., Belperio J.A., Keane M.P. Cytokines in innate host defense in the lung. J. Clin. Invest. 2002, 109:699-705.
34. Thorley A.J., Ford P.A., Giembycz M.A., Goldstraw P., Young A., Tetley T.D. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J. Immunol. 2007, 178:463-473.
35. Tsai W.C., Strieter R.M., Mehrad B., Newstead M.W., Zeng X., Standiford T.J. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 2000, 68:4289-4296.
36. Tsai W.C., Strieter R.M., Wilkowski J.M., Bucknell K.A., Burdick M.D., Lira S.A., Standiford T.J. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol. 1998, 161:2435-2440.
37. Uchida T., Shirasawa M., Ware L.B., Kojima K., Hata Y., Makita K., Mednick G., Matthay Z.A., Matthay M.A. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 2006, 173:1008-1015.
38. van der Poll T., Marchant A., Keogh C.V., Goldman M., Lowry S.F. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 1996, 174:994-1000.
39. van Zoelen M.A., Florquin S., de B.R., Pater J.M., Verstege M.I., Meijers J.C., van der Poll T. Urokinase plasminogen activator receptor-deficient mice demonstrate reduced hyperoxia-induced lung injury. Am. J. Pathol. 2009, 174:2182-2189.
40. van Zoelen M.A., Florquin S., Meijers J.C., de B.R., de Vos A.F., de Boer O.J., van der Poll T. Platelet-activating factor receptor contributes to host defense against Pseudomonas aeruginosa pneumonia but is not essential for the accompanying inflammatory and procoagulant response. J. Immunol. 2008, 180:3357-3365.
41. van Zoelen M.A., van der Sluijs K.F., Achouiti A., Florquin S., Braun-Pater J.M., Yang H., Nawroth P.P., Tracey K.J., Bierhaus A., van der Poll T. Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia. Virology 2009, 391:265-273.
42. von Aulock S., Morath S., Hareng L., Knapp S., van Kessel K.P., van Strijp J.A., Hartung T. Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment. Immunobiology 2003, 208:413-422.
43. Yamamoto S., Tin-Tin W.S., Ahmed S., Kobayashi T., Fujimaki H. Effect of ultrafine carbon black particles on lipoteichoic acid-induced early pulmonary inflammation in BALB/c mice. Toxicol. Appl. Pharmacol. 2006, 213:256-266.
44. Yipp B.G., Andonegui G., Howlett C.J., Robbins S.M., Hartung T., Ho M., Kubes P. Profound differences in leukocyte-endothelial cell responses to lipopolysaccharide versus lipoteichoic acid. J. Immunol. 2002, 168:4650-4658.
45. Zisman D.A., Kunkel S.L., Strieter R.M., Tsai W.C., Bucknell K., Wilkowski J., Standiford T.J. MCP-1 protects mice in lethal endotoxemia. J. Clin. Invest. 1997, 99:2832-2836.